Backed by Cantor Fitzgerald Following Physician Survey

finance.yahoo.com/news/neuropace-inc-npce-backed-cantor-173539144.html

In This Article:
NeuroPace, Inc. (NASDAQ:NPCE) is among the best NASDAQ stocks under $50 to buy. Cantor Fitzgerald reiterated its Overweight rating on NeuroPace, Inc. (NASDAQ:NPCE), with a price target of $16.00, implying an upside of nearly 44%. This affirmation is based on a survey of…

This story appeared on finance.yahoo.com, 2025-06-17 17:35:39.
The Entire Business World on a Single Page. Free to Use →